Escolar Documentos
Profissional Documentos
Cultura Documentos
Komen
In 1980, Nancy G. Brinker promised her dying sister, Susan, that she would do everything I her
power to end breast cancer forever. In 1982, that promise became the Susan G. Komen
organization and the beginning of a global movement. What was started with $200 and a
shoebox full of potential donor names has not grown to the worlds largest and most progressive
grassroots breast cancer organization, funding more breast cancer research than any other
nonprofit while providing real-time help to those facing the disease. To date, the organization
has invested more than $2.5 billion in groundbreaking research, community health outreach,
advocacy and programs in more than 30 countries. With the help of Komen-funded research,
the breast cancer death rate in the US has fallen by 34.0 percent in 20 years, Five-year relative
survival rates for women with early stage cancers are at 98.0 percent (up from 74.0 percent).
Affiliate History
Susan G. Komen Central Georgia was established in 1999 by a dedicated group of health
care providers and volunteers who wanted to find a way to fund breast health programs from
uninsured and underserved populations in Central Georgia. The first Susan G. Komen Race for
the Cure was held in Macon, Georgia in 2000. Over the past 17 years, the Affiliate has grown
from a small, core group to a network of thousands of survivors, activists, and community
leaders. The Affiliate serves eight counties, Baldwin, Crawford, Houston, Jones, Macon-Bibb,
Monroe, Peach, and Twiggs. The Central Georgia Affiliate currently has 2 full-time staff: the
Executive Director and the Affiliate Coordinator. There are 11 members of the 2014-2015 Board
of Directors, which is a working board that ensures the efforts and initiatives of the Affiliate are
aligned with the vision of the organizations. The Affiliate also relies on the generosity of more
than 100 volunteers, Community Health Interns, Communications Interns, and Community
Profile Interns who provide thousands of hours of volunteer work every year.
Mission
Susan G. Komens promise is to save lives and end breast cancer forever by empowering
others, ensuring quality care for all and investing in science to find the cures.
Impact
Working to meet this promise, Komen Central Georgia distributes up to 75.0 percent of its net
income to fund local community-based breast health education, screening and treatment
programs. The remaining 25.0 percent funds national research to find the cures for breast
cancer. In the past seventeen years, Komen Central Georgia has raised more than $2.5 million
through donations and fundraising events to fund the fight against breast cancer. The Affiliate
has awarded more than $1.8 million to local organizations for screening, education, and
treatment and more than $680,000 to national Komen research.
Service Area
The Central Georgia service area is home to approximately 451,970 residents and is spread of
eight counties: Baldwin, Crawford, Houston, Jones, Macon-Bibb, Monroe, Peach, Twiggs.
Approximately 66.9 percent of the population lines in the service areas largest counties,
Houston and Macon-Bibb. The majority of the service area is rural with two distinct metropolitan
cities: Macon and Warner Robins. White individuals make up approximately 53.8 percent of the
population; 39.6 percent are Black; additionally 0.4 percent are American Indian/Alaskan
Natives, 2.0 percent are Asian/ Pacific Islanders, and 4.3 percent of the population identify
themselves as Hispanic/Latina.
One in eight women in the United States will be diagnosed with breast cancer in her lifetime.
This challenge is particularly acute in the Komen Central Georgia service area. Thirty-nine
percent of the Central Georgia Population have an annual income 250 percent below the
poverty level, 9.6 percent are unemployed, 45.6 percent live in medically underserved areas
and 17.5 percent for not have health insurance. The Affiliates education level and income level
are slightly lower than the US as a whole. Each of these socioeconomic factors may contribute
to increased late-stage diagnosis and death rates.
Quick Facts
Early detection and effective treatment for breast cancer have been shown to improve
survival
1 in 8 women will get breast cancer in her lifetime; 1 in 1000 men will get breast cancer
in his lifetime.
Except for skin cancer, breast cancer is the most common cancer among women in the
US, accounting for nearly 29.0 percent of newly diagnosed cancers.
One case of breast cancer is diagnosed every 2 minutes, and one woman will die of
breast cancer every 13 minutes in the US.
Although breast cancer is more common in women over the age of 40, younger women
can also get breast cancer.
African American and Hispanic/Latina women are more likely than white women to be
diagnosed with later stage breast cancers. They also tend to have larger tumors.
Magnetic resonance imaging (MRI) test that creates an image of the breast often used with
mammography for screening women at a high risk of breast cancer
Malignant cancerous
Mammogram an x-ray of the breast; the best screening tool used today to find breast cancer
early
Metastasis the spread of cancer from the breast to other parts of the body
Oncologist a doctor who specializes in treating people with cancer
Postmenopausal hormones synthetic hormones used to relieve menopausal symptoms
Progesterone a hormone released by the ovaries during menstrual cycle
Progestin a synthetic progesterone-like ingredient found in postmenopausal hormone drug
Prognosis the expected or probable outcome of a disease; chance of recovery
Prosthesis (breast) an artificial breast form that can be wore under clothing after a mastectomy
Radiation therapy treatment using high energy x-rays to destroy cancer cells
Receptor a specific location in a cancer cell that hormones attach to promoting growth
Reconstructive surgery a procedure using plastic surgery to recreate a breast
Recurrence a return of cancer in the same site or another location
Risk factors factors that increase a persons chances of getting breast cancer
Stages of cancer a numbering system from 0-4 that indicates how advanced a cancer is with 0
being the least advanced
Tumor an abnormal growth or mass of tissue which may be benign or malignant